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Abstract
Introduction: Although caspase-8 is a well-established initiator of apoptosis and suppressor of necroptosis, recent
evidence suggests that this enzyme maintains functions beyond its role in cell death. As cells of the innate immune
system, and in particular macrophages, are now at the forefront of autoimmune disease pathogenesis, we
examined the potential involvement of caspase-8 within this population.
Methods: CreLysMCasp8fl/fl mice were bred via a cross between Casp8fl/fl mice and CreLysM mice, and RIPK3−/−CreLysMCasp8fl/fl
mice were generated to assess the contribution of receptor-interacting serine-threonine kinase (RIPK)3.
Immunohistochemical and immunofluorescence analyses were used to examine renal damage. Flow cytometric
analysis was employed to characterize splenocyte distribution and activation. CreLysMCasp8fl/fl mice were treated with
either Toll-like receptor (TLR) agonists or oral antibiotics to assess their response to TLR activation or TLR agonist
removal. Luminex-based assays and enzyme-linked immunosorbent assays were used to measure cytokine/chemokine
and immunoglobulin levels in serum and cytokine levels in cell culture studies. In vitro cell culture was used to assess
macrophage response to cell death stimuli, TLR activation, and M1/M2 polarization. Data were compared using the
Mann–Whitney U test.
Results: Loss of caspase-8 expression in macrophages promotes onset of a mild systemic inflammatory disease, which
is preventable by the deletion of RIPK3. In vitro cell culture studies reveal that caspase-8–deficient macrophages are
prone to a caspase-independent death in response to death receptor ligation; yet, caspase-8–deficient macrophages
are not predisposed to unchecked survival, as analysis of mixed bone marrow chimeric mice demonstrates that
caspase-8 deficiency does not confer preferential expansion of myeloid populations. Loss of caspase-8 in macrophages
dictates the response to TLR activation, as injection of TLR ligands upregulates expression of costimulatory CD86 on
the Ly6ChighCD11b+F4/80+ splenic cells, and oral antibiotic treatment to remove microbiota prevents splenomegaly
and lymphadenopathy in CreLysMCasp8fl/fl mice. Further, caspase-8–deficient macrophages are hyperresponsive to TLR
activation and exhibit aberrant M1 macrophage polarization due to RIPK activity.
Conclusions: These data demonstrate that caspase-8 functions uniquely in macrophages by controlling the response
to TLR activation and macrophage polarization in an RIPK-dependent manner.
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Introduction
Caspase-8 is intimately involved in two essential death
pathways—apoptosis and necroptosis—that are respon-
sible for the fate of a cell. Stimulation of a death receptor
(DR), such as Fas or tumor necrosis factor (TNF) receptor
1, by its ligand promotes recruitment of Fas-associated
death domain protein (FADD) [1]. This protein aggrega-
tion facilitates recruitment of the cysteine-aspartic acid
enzyme pro-caspase-8, which becomes active upon
dimerization. Active caspase-8 initiates the degradative
phase of apoptosis through activation of caspases-3/7 or
blocks necroptosis via suppression of receptor-interacting
serine/threonine protein kinase (RIPK)1-RIPK3 signaling,
depending upon the availability of cellular FADD-like
interleukin (IL)-1β-converting enzyme-inhibitory protein
(cFLIP) [1, 2]. Low levels of cFLIP allow caspase-8 homo-
dimers to form, and apoptosis ensues [2]. Conversely, high
levels of cFLIP enable formation of caspase-8-cFLIP
heterodimers, which limit RIPK1-RIPK3 signaling for
necroptosis and prevent apoptosis [2]. In the absence of
caspase-8, apoptosis may not occur, but RIPK1-RIPK3 sig-
naling proceeds unchecked, leading to necroptosis [2].
Further, evidence is emerging that suggests that caspase-8
also maintains cell type–specific, RIPK-dependent, cell
death–independent functions, including interferon regula-
tory factor IRF3 processing for degradation [3, 4], IL-1β
production [5, 6], inflammasome activation [5, 7], and
Toll-like receptor (TLR) signaling [8].
We previously showed that conditional deletion of Fas
or caspase-8 specifically in innate immune cells supports a
role for these signaling components in cell activation. An
aggressive systemic lupus erythematosus (SLE)-like dis-
ease develops in mice following myeloid cell–specific
deletion of Fas (CreLysMFasfl/fl) [9] or dendritic cell
(DC)-specific deletion of caspase-8 (CreCD11cCasp8fl/fl)
[10]. CreLysMFasfl/fl are also more susceptible than control
mice to lipopolysaccharide (LPS)-induced shock [9]. In
addition, caspase-8–deficient bone marrow–derived den-
dritic cells (BMDCs) are hyperresponsive to TLR activation
in an RIPK1-dependent manner, and CreCD11cCasp8fl/fl
splenic DCs upregulate costimulatory molecules in re-
sponse to in vivo administration of TLR agonists [10].
Further, deletion of MyD88 in CreCD11cCasp8fl/fl mice pre-
vents SLE-like disease, although oral antibiotic treatment is
ineffective at diminishing inflammatory phenotypes [10].
Because these data reveal a cell-specific role for Fas in
myeloid cells and caspase-8 in DCs in the regulation of
TLR signaling, we evaluated the consequences of caspase-
8 deletion in the myeloid cell compartment.
We now document that caspase-8 functions in mye-
loid cells to maintain macrophage activation, in part
through RIPK1 and RIPK3. Specific deletion of caspase-
8 in myeloid cells (CreLysMCasp8fl/fl) leads to the devel-
opment of a mild systemic inflammation characterized
by splenomegaly, lymphadenopathy, immune complex
deposition in the kidney, proteinuria, hypergammaglobu-
linemia, and elevated amounts of serum cytokines that is
preventable by RIPK3 deletion. Although Ly6Chigh and
Ly6Clow CD11b+F4/80+ splenic populations are in-
creased in CreLysMCasp8fl/fl mice, these cells are insuffi-
cient inducers of antigen-specific T-cell proliferation. In
vitro cell culture studies reveal that caspase-8–deficient
macrophages are prone to a caspase-independent death
in response to DR ligation; yet, caspase-8–deficient
myeloid populations are not predisposed to unchecked
survival, as analysis of mixed bone marrow chimeric
mice demonstrates that caspase-8 deficiency does not
confer preferential expansion of myeloid populations.
Despite the relatively mild inflammatory phenotype
of CreLysMCasp8fl/fl mice, caspase-8–deficient bone
marrow–derived macrophages (BMDMs) are hyperre-
sponsive to TLR activation in an RIPK1-dependent man-
ner. Further, myeloid cell–specific caspase-8 deficiency
appears to dictate the in vivo response to TLR activation,
as injection of TLR ligands into CreLysMCasp8fl/fl mice
upregulates the expression of costimulatory CD86 on the
Ly6ChighCD11b+F4/80+ splenic population. In addition,
oral antibiotic treatment prevents inflammatory disease
phenotypes in young CreLysMCasp8fl/fl mice. Moreover,
caspase-8 controls the polarization of macrophages in re-
sponse to M1-skewing media in an RIPK1-dependent
manner. These data document a role for caspase-8 as a
regulator of both the TLR response and macrophage
polarization via limiting RIPK in macrophages.
Methods
Mice
C57BL/6 (B6) mice homozygous for loxP-flanked caspase-
8 allele (Casp8fl/fl) [11] were crossed with mice expressing
Cre under control of murine lysozyme M gene promoter
(CreLysM; The Jackson Laboratory, Bar Harbor, ME, USA),
generating CreLysMCasp8fl/fl mice. CreLysMCasp8fl/fl mice
were crossed with RIPK3−/− (Genentech, South San
Francisco, CA, USA) to generate RIPK3−/−CreLysMCasp8fl/fl
mice. OT-II/RAG−/− and B6.CD45.1 were purchased from
The Jackson Laboratory. B6.CD45.1/2mice were generated
from a cross of B6 (The Jackson Laboratory) and
B6.CD45.1 mice. Female mice were used in all studies.
Proteinuria was assessed using Uristix reagent strips
(Siemens Healthcare Diagnostics, Tarrytown, NY, USA).
Transnetyx (Cordova, TN, USA) performed all genotyping
of mice. All animal experiments were approved by the
Northwestern University Institutional Animal Care and
Use Committee.
Histopathologic studies
Paraffin-embedded kidney sections (5 μm) were treated
with periodic acid–Schiff stain, and a pathologist blinded
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to the study scored kidney sections using an Olympus
BS40 microscope (Olympus Life Science, Center Valley,
PA, USA) as previously described [12]. Frozen kidney
sections (10 μm) were stained with anti-IgG-fluorescein
isothiocyanate [12]. All images were photographed at ×
40, ×200, ×400, or × 600 magnification on an Olympus
BX41 microscope equipped with an Olympus DP20
camera.
Flow cytometry
Surface staining of cell suspensions and gating strategies
were carried out as previously described [9, 10, 13]. At
least 100,000 events were captured on a BD LSR II flow
cytometer (BD Biosciences, San Jose, CA, USA). Data
were analyzed with FlowJo software (Tree Star, Ashland,
OR, USA). Dead cells were excluded using the Molecu-
lar Probes LIVE/DEAD Fixable Aqua Dead Cell Stain
Kit (Life Technologies, Carlsbad, CA, USA). For cell-
sorting studies, splenocytes preincubated with Fc block
antibody were stained with fluorescent antibodies (infor-
mation available upon request). Splenocyte populations
sorted on a BD FACSAria II instrument (BD Biosci-
ences) at the University of Chicago and Northwestern
University Cancer Center Flow Core had an average pur-
ity of 97 %.
Mixed bone marrow chimeras
Bone marrow was aseptically harvested from tibias, fe-
murs, and humeri from 9-week-old mice and erythrocytes
were lysed (BD Pharm Lyse buffer; BD Biosciences). Cells
were incubated with Fc block antibody followed by incu-
bation with fluorochrome-conjugated antibodies against
B220, CD4, CD8, CD11b, Ly6G, NK1.1, Siglec F, Ter119,
c-Kit, and Sca-1 (BD Biosciences; and eBioscience and
BioLegend, both located in San Diego, CA, USA). Cell
suspensions were subjected to fluorescence-activated cell
sorting (FACS) analysis to obtain the Lin−Sca-1+c-kit+
(LSK) cell population. Three-month-old B6.CD45.1/2
received a single 1000-cGy γ-irradiation dose using a Cs-
137-based Gammacell 40 irradiator (Best Theratronics,
Ottawa, ON, Canada). After 12 h, 5 × 105 LSK cells were
intravenously injected from Casp8fl/fl, CreLysMCasp8fl/fl, a
mixture of Casp8fl/fl plus B6.CD45.1 or CreLysMCasp8fl/fl
plus B6.CD45.1 (1:1 ratio). Chimeric mice were main-
tained on trimethoprim/sulfamethoxazole (40 mg/5 mg,
respectively; Hi-Tech Pharmacal/Akorn, Amityville, NY,
USA) diluted in autoclaved water (2 ml antibiotics/500 ml
water) and phenotyped 8 months posttransfer.
In vitro assays
For mixed leukocyte reactions, splenocytes were incu-
bated with anti-CD19 beads and negative fractions were
incubated with anti-CD11b magnetic-activated cell
sorting beads (Miltenyi Biotec, Bergisch Gladbach,
Germany) to purify antigen-presenting cells (APCs).
Purified APCs were pulsed with 10 μg/ml ovalbumin
(OVA) peptide (amino acids 323–339) for 60 minutes at
37 °C. OVA-specific splenic CD4+ T cells were isolated
from B6.CD45.1/OT-II/RAG−/− mice using CD4+ T-cell
isolation kits (Miltenyi Biotec) according to the manu-
facturer’s instructions. Purity of APCs and T cells was
90 %. T cells were labeled with carboxyfluorescein diace-
tate succinimidyl ester (CFSE) (500 nM for 12 minutes
at 37 °C; Invitrogen, Carlsbad, CA, USA). Pulsed APCs
at various ratios were incubated with 2 × 105 CFSE-
labeled T cells with or without 5 μg/ml class B CpG
(ODN 1668; InvivoGen, San Diego, CA, USA) in tripli-
cate in 96-well flat-bottomed plates at 37 °C for 3 days.
Cell clusters were dissociated with 7.5 mM ethylenedi-
aminetetraacetic acid for 15 minutes, and stained with
anti-CD4 (BD Biosciences). 7-Aminoactinomycin D
(0.25 mg/test; BD Biosciences) was used to exclude dead
cells. A constant number of CaliBRITE beads (BD Bio-
sciences) were added for acquisition of equal parts in
each culture. Live T cells were gated, and the number of
divided cells showing less than maximal CFSE fluores-
cence intensity was determined.
BMDMs were generated by culturing bone marrow in
media (Dulbecco’s modified Eagle’s medium with 10 %
fetal calf serum, 2 mM glutamine, 100 U penicillin/
0.1 mg streptomycin/1 ml and 1 mM sodium pyruvate)
plus macrophage colony-stimulating factor (M-CSF;
100 ng/ml). On day 6, cells were replated at 1.75 × 106
cells/well in a 6-well plate, and on day 7 cells were stim-
ulated with the indicated treatments. For cytokine levels,
BMDMs were stimulated for 3, 6, and 12 h with LPS
(10 ng/ml), imiquimod (5 μg/ml), or CpG (5 μg/ml) with
or without necrostatin-1 (Nec-1; 30 μM), and cells were
harvested for cytokine transcript levels while superna-
tants were evaluated for cytokine levels (see below). Fol-
lowing TLR stimulation for the indicated time, ATP
(5 mM; Sigma-Aldrich, St. Louis, MO, USA) was added
to BMDMs for 45 minutes for evaluation of IL-1β levels
in supernatants. For BMDM death assays, BMDMs at a
concentration of 2 × 106 cells/ml were stimulated for
48 h with superFasL (100 ng/ml; Enzo Life Sciences,
Farmingdale, NY, USA), etoposide (10 μM; Alexis Biochem-
icals, Lausen, Switzerland) with or without carbobenzoxy-
valyl-alanyl-aspartyl-[O-methyl]-fluoromethylketone (Z-
VAD-FMK, 20 μM; Promega, Madison, WI, USA), and
supernatants were evaluated for lactate dehydrogenase
(LDH) activity according to the manufacturer’s instruc-
tions (Sigma-Aldrich). For splenocyte death assays, 3 × 106
total splenocytes were treated for 10 h with superFasL
(100 ng/ml; Enzo Life Sciences) or etoposide (10 μM;
Alexis Biochemicals) and stained with annexin-V and
Molecular Probes LIVE/DEAD Fixable Aqua Dead Cell
Stain. For macrophage polarization assays, BMDMs were
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cultured with M1-polarizing conditions (primed over-
night with interferon [IFN]-γ 100 ng/ml and stimu-
lated for 3 h with LPS [10 ng/ml]) and M2-polarizing
conditions (stimulated for 24 h with IL-4 [40 ng/mL])
with or without Nec-1 (30 μM) and/or Z-Ile-Glu(O-
ME)-Thr-Asp(O-Me)-FMK (Z-IETD-FMK, 20 μM; BD
Biosciences). Polarized BMDMs were lysed directly in
QuantiGene Lysis Mixture, and gene expression profiles
were determined using a custom QuantiGene 2.0 assay
(Affymetrix, Santa Clara, CA, USA) and a Luminex 200
instrument (Luminex Corporation, Austin, TX, USA) (see
Additional file 1: Table S1 for panel description).
In vivo assays
For TLR ligand injection studies, 3-month-old mice
were intraperitoneally injected with LPS, imiquimod, or
CpG (200 μg/20 g body weight; InvivoGen) and analyzed
after 4 h by FACS analysis. For oral antibiotic treatment,
3-week-old mice were given autoclaved water plus ampi-
cillin (1 g/L), vancomycin (0.5 g/L), neomycin sulfate
(1 g/L), metronidazole (1 g/L), and sucrose (10 g/L)
twice weekly for 8 weeks with no observable weight loss.
Western blot analysis, antibody/cytokine measurements,
and gene expression quantification
Sorted splenocytes and BMDMs were lysed in sample
buffer, and equal amounts of proteins were separated by
SDS-PAGE, transferred onto polyvinylidene difluoride
membranes, and analyzed by immunoblotting with the
appropriate primary antibodies (caspase-8, Enzo Life
Sciences; glyceraldehyde 3-phosphate dehydrogen-
ase [GAPDH], US Biological, Salem, MA, USA) and
horseradish peroxidase (HRP)-conjugated secondary anti-
bodies (goat anti-rat immunogloblulin G [IgG]-HRP;
Santa Cruz Biotechnology, Santa Cruz, CA, USA), electro-
chemiluminescence detection (Pierce/Thermo Scientific,
Waltham, MA, USA), and image acquisition (Ultra-Lum,
Claremont, CA, USA). Single-stranded DNA (ssDNA)-,
double-stranded DNA (dsDNA)-, histone-, or chromatin-
reactive IgG antibodies were measured as previously de-
scribed [12]. Total IgM and IgG isotypes and cytokine/
chemokine expression were quantified using Luminex
bead-based assays (Affymetrix) and enzyme-linked im-
munosorbent assays (ELISAs). Total RNA was isolated
from BMDMs using the RNeasy Plus Mini Kit according
to the manufacturer’s instructions (Qiagen, Valencia, CA,
USA). RNA was reverse-transcribed with the High Cap-
acity RNA-to-cDNA kit (Applied Biosystems, Foster City,
CA, USA). Real-time PCR was performed on an ABI 7300
real-time PCR machine (Applied Biosystems) using the
TaqMan gene expression system (Applied Biosystems)
and predesigned fluorescein-labeled primer/probes (β-
actin, IL-6: Mm00446190_m1; IL-10: Mm00439614_m1;
TNF-α: Mm00443258_m1; IL-1β: Mm00434228_m1; IL-
12b: Mm00434174_m1; Life Technologies). The results
are presented as relative expression compared with β-
actin.
Data analysis
For analysis of macrophage polarization, data were nor-
malized to expression of housekeeping genes and imported
into Partek Genomics Suite V6.6 software (Partek, St.
Louis, MO, USA). Differentially expressed genes between
the different groups of stimulated macrophages, as well as
transcripts with variable expression within the data set,
were calculated using one-way analysis of variance
(ANOVA). Differentially expressed genes between two an-
alyzed macrophage populations were defined by a
Bonferroni-corrected p value <0.05 unless stated other-
wise. Principal component analysis (PCA) using all tran-
scripts was performed for visualization of sample
relationships. Hierarchical clustering of the differentially
expressed genes was performed based on a Euclidean
algorithm for dissimilarity and average linkage method to
determine distance between clusters. All other data
are shown as mean ± SD and were compared by Mann–
Whitney U test using GraphPad Prism 5.0 software
(GraphPad Software, San Diego, CA, USA).
Results
Mice with conditional deletion of caspase-8 in myeloid
cells develop a mild systemic inflammatory disease
The authors of a previous report demonstrated that
CreLysMCasp8fl/− mice failed to generate caspase-8 defi-
ciency in myeloid cells or an observable phenotype [14].
However, in the present study, CreLysMCasp8fl/fl mice exhib-
ited caspase-8 deletion specifically in myeloid populations.
PCR and immunoblot analysis of FACS-sorted splenic neu-
trophils (CD11b+Ly6G+) and Ly6Clow and Ly6Chigh CD11b+
F4/80+ cells (Additional file 1: Figure S1a, b) and M-CSF-
generated BMDMs (Additional file 1: Figure S2,a, b) from
CreLysMCasp8fl/fl mice showed caspase-8 deletion, whereas
lymphocytes and DC populations retained caspase-8. Fur-
ther, there was no defect in the generation of BMDMs
from mice with myeloid cell–specific caspase-8 deficiency
(Additional file 1: Figure S2,c, d). Loss of caspase-8 in
myeloid cells led to splenomegaly in both young and aged
mice (Fig. 1a, b). However, there was no increase in total
splenocyte numbers (Fig. 1c). In addition, lymphadenop-
athy was present in young and aged CreLysMCasp8fl/fl mice
(Fig. 1d). CreLysMCasp8fl/fl mice failed to develop glomer-
ulonephritis (Fig. 1e, f ), although mild IgG deposition in
the kidney (Fig. 1e) and higher proteinuria levels (Fig. 1g)
were detected compared with control mice. Further,
CreLysMCasp8fl/fl mice displayed elevated levels of IgG2b
and total IgM antibodies (Fig. 1i) but did not show evi-
dence of circulating autoreactive antibodies (Fig. 1h).
Moreover, serum levels of proinflammatory molecules
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soluble receptor activator of nuclear factor κB ligand
(sRANKL) and keratinocyte chemoattractant/growth-reg-
ulated oncogene-α (KC/Gro-α) (Fig. 1j) were elevated
compared with levels in control mice. Mortality was simi-
lar between CreLysMCasp8fl/fl and control mice (Fig. 1k).
These data indicate that myeloid cell–specific deletion of
caspase-8 induces a mild systemic inflammatory disease
that may be mediated by enhanced circulating cytokines
and chemokines.
Myeloid cell-specific loss of caspase-8 increases splenic
CD11b+F4/80+ populations
To determine the cellular mechanism responsible for
the mild inflammatory phenotype that arises in
Fig. 1 Mice with conditionally deleted caspase-8 exhibit mild systemic inflammation. We evaluated 2–3-month old (young) and 6–8-month-old
(aged) female Casp8fl/fl (control) and CreLysMCasp8fl/fl mice (n≥ 4) for systemic autoimmune disease phenotypes. a Representative spleens and cervical
lymph nodes from aged mice. b Spleen weights of young and aged mice. c Total numbers of live splenocytes from young and aged mice. d Cervical
lymph node weights of young and aged mice. e Formalin-fixed kidney sections (5 μm) of aged mice stained with periodic acid–Schiff (PAS) and frozen
kidney sections (10 μm) stained with IgGα-fluorescein isothiocyanate. f Kidney score of aged mice. g Proteinuria of aged mice assessed using Uristix
reagent strips. Serum from aged mice was evaluated for levels of h ssDNA-, dsDNA-, histone-, and chromatin-reactive IgG antibodies; i total IgM and
IgG isotypes; and j cytokines and chemokines. k Survival study. Data are represented as mean ± SD and were compared by Mann–Whitney U test:
*p < 0.05; ***p < 0.0005. Casp8 caspase-8, dsDNA double-stranded DNA, Gro-α growth-regulated oncogene-α, IFN interferon, Ig immunoglobulin,
IL interleukin, KC keratinocyte chemoattractant, LN lymph node, MCP monocyte chemoattractant protein, OD optical density, sRANKL soluble receptor
activator of nuclear factor κB ligand, ssDNA single-stranded DNA, TNF tumor necrosis factor
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CreLysMCasp8fl/fl mice, multiparameter flow cytometry was
used. CreLysMCasp8fl/fl mice exhibited increased numbers of
Ly6Chigh and Ly6Clow splenic CD11b+F4/80+ cells, whereas
the CD11b+F4/80−Ly6G+ neutrophils and CD11b−F4/80+
red pulp macrophage populations were not statistically al-
tered compared with control mice (Fig. 2a). Although in-
creased in numbers, no significant alterations in surface
expression of activation markers were observed on caspase-
8–deficient Ly6Chigh and Ly6Clow splenic CD11b+F4/80+
cells compared with control populations (Fig. 2b). CreLysM-
Casp8fl/fl mice also showed no statistical difference in con-
ventional and plasmacytoid DC numbers (Fig. 2c) or
activation status (Fig. 2d) compared with control mice. The
lymphocytic populations were then evaluated to determine
whether the increased presence of CreLysMCasp8fl/fl
Ly6Chigh and Ly6Clow splenic CD11b+F4/80+ cells affected
B- and T-cell functionality. Loss of caspase-8 in myeloid
cells had no observable effect on total B-cell numbers
(Fig. 2e), subset distribution (Fig. 2f), or activation and mat-
uration (Fig. 2g). In addition, CreLysMCasp8fl/fl mice did not
exhibit any alterations in CD4+ or CD8+ total, naïve (CD44
−CD62L+), or activated (CD44+CD62L−) T cells or in the
numbers of double-negative T cells (CD4−CD8−CD3+B220
+), which are associated with deficiencies in Fas [15–17]
(Fig. 2h). Activated CD4+ and CD8+ T cells expressed simi-
lar levels of CD69 and PD-1 (Fig. 2i), and regulatory T-cell
numbers were unchanged (Fig. 2j), between CreLysMCasp8fl/
fl and control mice. Additionally, the capacity for antigen
presentation to T cells was assessed. Caspase-8–deficient
CD11b+ cells incubated with OVA peptide suppressed OT-
II-specific (C57BL/6-Tg(TcraTcrb)425Cbn/Crl) CD4+ T-cell
proliferation in the presence or absence of TLR9 activation
compared with control CD11b+ cells (Fig. 2k). Taken to-
gether, these results suggest that, although there are in-
creased numbers of Ly6Chigh and Ly6Clow splenic CD11b
+F4/80+ cells in CreLysMCasp8fl/fl mice, these cells do not
promote heightened activation and functionality of sur-
rounding cells and in fact are capable of suppressing CD4+
T-cell proliferation on a per-cell basis.
Caspase-8 deficiency alters macrophage TLR responses in
vivo but has a minimal effect on myeloid cell homeostasis
As TLRs play a central role in macrophage activation, we
assessed the in vivo expression pattern of TLRs and re-
sponse to TLR agonists of macrophages in the absence of
caspase-8. TLR2, TLR4, TLR7, and TLR9 expression was
similar between CreLysMCasp8fl/fl and control Ly6Chigh
and Ly6Clow splenic CD11b+F4/80+ cells (Fig. 3a). To
determine the functional response of these TLRs in
caspase-8–deficient populations, LPS, imiquimod, or CpG
was intraperitoneally injected into CreLysMCasp8fl/fl and
control mice. Both TLR4 and TLR9 in vivo activation in-
duced increased CD86 expression on caspase-8–deficient
Ly6Chigh splenic CD11b+F4/80+ cells compared with
control cells (Fig. 3b). These data suggest that, although
this population expressed CD86 at normal levels under
steady-state conditions, caspase-8 deficiency confers the
capacity to upregulate this costimulatory marker upon
TLR activation. Further, TLR4 and TLR9 in vivo activation
induced elevated levels of circulating anti- and proinflam-
matory cytokines in CreLysMCasp8fl/fl and control mice
(Fig. 3c and Additional file 1: Figure S3), but to a much
greater extent in control mice in response to TLR4 ac-
tivation (Fig. 3c). Over the past several years, gut
microflora have been suggested to be a reservoir for
endogenous TLR ligands [18, 19]. To reduce the po-
tential for endogenous TLR ligands from gut micro-
flora, young CreLysMCasp8fl/fl mice were treated with
oral antibiotics, which prevented both splenomegaly
(Fig. 3d) and lymphadenopathy (Fig. 3e) compared
with untreated CreLysMCasp8fl/fl mice.
Further, the survival of myeloid cell subsets was exam-
ined using mixed bone marrow chimeric mice (Fig. 3f )
maintained on low-dose oral antibiotics. As expected on
the basis of our prior results with oral antibiotic treat-
ment, mixed bone marrow chimeric mice (wild-type
[WT] +CreLysMCasp8fl/fl) did not display splenomegaly or
lymphadenopathy (Fig. 3g, h). However, proteinuria per-
sisted in these mice despite low-dose oral antibiotic treat-
ment (Fig. 3i). Consistent with our observations in aged
CreLysMCasp8fl/fl mice, serum levels of sRANKL were ele-
vated in WT+CreLysMCasp8fl/fl mice compared with WT+
Casp8fl/fl mice (Fig. 3j). Loss of caspase-8 in myeloid cells
did not result in enhanced survival, as splenic myeloid cell
numbers remained unchanged in mixed bone marrow
chimeric mice (Fig. 3k). Further, there was no preferential
expansion of CD11b+ CreLysMCasp8fl/fl-derived splenic mye-
loid populations in mixed bone marrow chimeric mice
(Fig. 3l). These data indicate that loss of caspase-8 in vivo
does not confer a survival advantage to splenic myeloid cells.
However, we observed that the CreLysMCasp8fl/fl-derived
CD11b−F4/80+ red pulp macrophage population exhibited
reduced expansion in mixed bone marrow chimeric mice.
Taken together, these data suggest that caspase-8 in mye-
loid cells controls the TLR response to the gut microflora
and plays a only minor role in myeloid cell survival.
Because caspase-8 is a downstream signaling compo-
nent of the DR Fas, the responses to cell death stimuli
were evaluated in caspase-8–deficient myeloid cells.
Total splenocytes from CreLysMCasp8fl/fl and control
mice were incubated with either Fas ligand (FasL) or
etoposide. Whereas ex vivo splenic Ly6Chigh and Ly6Clow
CD11b+F4/80+ cells were susceptible to both FasL-
induced (Additional file 1: Figure S4a, b) and etoposide-
induced (Additional file 1: Figure S4a, c) death, splenic
neutrophils appeared responsive only to FasL. Thus, the
availability of caspase-8 had no effect on the level of cell
death in response to either treatment.
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Fig. 2 (See legend on next page.)
Cuda et al. Arthritis Research & Therapy  (2015) 17:291 Page 7 of 16
RIPK3 deletion prevents inflammatory phenotypes in
CreLysMCasp8fl/fl mice
Owing to involvement of caspase-8 in limiting RIPK3 activ-
ity [2], we generated RIPK3−/−CreLysMCasp8fl/fl mice. Dele-
tion of RIPK3 prevented inflammatory disease phenotypes
observed in CreLysMCasp8fl/fl mice. Splenomegaly was re-
duced in both young and aged RIPK3−/−CreLysMCasp8fl/fl
mice compared with CreLysMCasp8fl/fl mice (Fig. 4a), with
no alteration in total splenocyte numbers (Fig. 4b).
Lymphadenopathy was also abated in both young and
aged RIPK3−/−CreLysMCasp8fl/fl mice compared with
CreLysMCasp8fl/fl mice (Fig. 4c). Similar to control and
CreLysMCasp8fl/fl mice, RIPK3−/−CreLysMCasp8fl/fl mice
showed little evidence of kidney damage (Fig. 4d, e). How-
ever, a trend toward reduced proteinuria levels (Fig. 4f) was
detected in RIPK3−/−CreLysMCasp8fl/fl mice compared with
CreLysMCasp8fl/fl mice. Similar to CreLysMCasp8fl/fl mice,
there was no evidence of circulating ssDNA, dsDNA, or
histone IgG antibodies in RIPK3−/−CreLysMCasp8fl/fl mice
(Fig. 4g). However, there was a trend toward increased
dsDNA + histone IgG antibodies in serum from
RIPK3−/−CreLysMCasp8fl/fl mice compared with control
and CreLysMCasp8fl/fl mice (Fig. 4g). Further, elevated
serum levels of sRANKL in CreLysMCasp8fl/fl mice (Fig. 2)
were reversed with deletion of RIPK3. Moreover, the in-
creased numbers of splenic Ly6ChighCD11b+F4/80+,
Ly6ClowCD11b+F4/80+, and Ly6G+ (neutrophils) cells in
CreLysMCasp8fl/fl mice were restored to control levels by
deletion of RIPK3 (Fig. 4i). Although CreLysMCasp8fl/fl
mice showed no statistical difference in DC numbers
compared with control mice, RIPK3−/−CreLysMCasp8fl/fl
mice exhibited increased numbers of conventional DCs
compared with CreLysMCasp8fl/fl mice (Fig. 4j). Addition-
ally, whereas total B-cell numbers were unaffected in
RIPK3−/−CreLysMCasp8fl/fl mice (Fig. 4k), there was a de-
crease in the CD19+CD21/35+CD23+ follicular B-cell com-
partment in RIPK3−/−CreLysMCasp8fl/fl mice compared with
CreLysMCasp8fl/fl mice (Fig. 4l). However, in CreLysMCasp8fl/fl
mice, deletion of RIPK3 did not affect numbers of total
CD4+ or CD8+ (Fig. 4m), naïve or activated CD4+ (Fig. 4n)
or CD8+ (Fig. 4o), double-negative (Fig. 4p), or regulatory
T cells (Fig. 4q). These results suggest that the inflamma-
tion observed in CreLysMCasp8fl/fl mice arises in part from
unchecked RIPK3 activity, as deletion of RIPK3 can re-
store these aberrant phenotypes to normal.
Previous studies in lymphocytes showed that loss of
caspase-8 results in necroptosis, which is mediated by
RIPK1/RIPK3 signaling. Therefore, the role that caspase-
8 plays in macrophage death was evaluated in vitro. M-
CSF-generated caspase-8–deficient BMDMs expressed
Fas under steady-state conditions, which was upregu-
lated with TLR activation (Additional file 1: Figure S5).
Without stimulation, BMDMs deficient in caspase-8,
RIPK3, or both caspase-8 and RIPK3 displayed increased
LDH activity, indicating an increase in cell death. Similar
to ex vivo caspase-8–deficient myeloid populations,
caspase-8–deficient BMDMs responded like control
BMDMs to FasL and etoposide at 48 h (Additional file 1:
Figure S6) posttreatment, despite the overall higher cell
death in caspase-8–deficient BMDM cultures. However,
unlike in control BMDMs, the addition of Z-VAD did not
reverse the death induced by FasL in caspase-8–deficient
cells (Additional file 1: Figure S6), indicating that
these caspase-8–deficient BMDMs underwent a caspase-
independent cell death. Deletion of RIPK3 in caspase-8–
deficient BMDMs restored the response to that of control
BMDMs, as the addition of Z-VAD blocked death in
RIPK3−/−CreLysMCasp8fl/fl BMDMs. Taken together, these
results suggest that caspase-8 deficiency predisposes
macrophages to caspase-independent cell death upon
DR ligation.
Caspase-8 deficiency in macrophages alters the response
to TLR activation and macrophage polarization in vitro
To expand upon these studies, caspase-8–deficient
BMDMs were treated with LPS, imiquimod, or CpG in
(See figure on previous page.)
Fig. 2 Splenic cellularity and activation profiles of CreLysMCasp8fl/fl mice are not drastically altered. Splenocytes from 6–8-month-old (aged) female
Casp8fl/fl (control) and CreLysMCasp8fl/fl mice (n≥ 4) were analyzed by flow cytometry. a Number of CD11b+F4/80−Ly6G+ neutrophils, Ly6Chigh and
Ly6Clow CD11b+F4/80+ cells, and CD11b−F4/80+ red pulp macrophages. b Representative fluorescence-activated cell sorting (FACS) plots of
CD11b+F4/80+Ly6Chigh and CD11b+F4/80+Ly6Clow splenocytes displaying levels of surface activation marker expression. c Number of CD11c+CD8−
and CD11c+CD8− conventional DCs and CD11cintermediatePDCA-1+B220+ plasmacytoid DCs. d Representative FACS plots of CD11c+CD8− and
CD11c+CD8− conventional DCs and CD11cintermediatePDCA-1+B220+ plasmacytoid DCs displaying levels of surface activation marker expression.
e Total B-cell (CD11c−B220+) numbers. f B-cell subsets: follicular (FO; CD19+CD21/35+CD23+), marginal zone (MZ; CD19+CD21/35+CD23low),
transitional 1 (T1; B220+AA4.1+CD23−), transitional 2 (T2; B220+AA4.1+CD23+), plasmablasts (PB; CD19+B220lowCD138+CD21/35−CD23−), and plasma
cells (PC; CD19+B220+CD138+CD21/35−CD23−). g Representative FACS plots from B cells displaying levels of surface activation and maturation
marker expression. h Representative FACS plots and quantitative graphs of total CD4+ and CD8+ T-cell numbers, naïve (CD44−CD62L+), central
memory (CD44+CD62L+) and activated (CD44+CD62L−) CD4+ and CD8+ T-cell numbers, and CD4−CD8−CD3+B220+ double-negative T-cell
numbers. i Representative FACS plots and quantitative graphs depicting activated CD4+ and CD8+ T cells displaying levels of surface activation
marker expression. j CD4+CD25+Foxp3+ regulatory T-cell numbers. Data are represented as mean ± SD and were compared by Mann–Whitney
U test: **p < 0.005, ***p < 0.0005. k Bead-separated CD11b+ cells incubated with ovalbumin were cocultured with B6.CD45.1/OT-II/RAG−/− CD4+ T
cells at various ratios with or without CpG. Data are represented as mean ± SD of biological triplicates, and experiments were repeated twice. Data
were compared by Mann–Whitney U test: *p < 0.05; **p < 0.005. PDCA-1 plasmacytoid dendritic cell antigen 1
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the presence of absence of necrostatin-1 (Nec-1) and were
evaluated for cytokine transcript levels as well as levels of
cytokines in supernatants at indicated time points.
Caspase-8–deficient BMDMs showed reduced transcrip-
tion of IL-10 upon TLR7 and TLR9 ligation and reduced
IL-12/IL-23p40 transcription with TLR4, TLR7, and TLR9
activation compared with control BMDMs. However, IL-
10 transcript was elevated in caspase-8–deficient BMDMs
upon TLR4 stimulation (Additional file 1: Figure S7a, b).
Similar to transcription levels, caspase-8–deficient
BMDMs produced less IL-10 and IL-12/IL-23p40 with
TLR4, TLR7, and TLR9 ligation compared with control
BMDMs (Additional file 1: Figure S7a, b). However, both
transcript and protein levels of IL-10 and IL-12/IL-23p40
were restored to control levels with RIPK3 deletion, but
not with blockade of RIPK1 kinase activity via the addition
of Nec-1 (Additional file 1: Figure S7a, b).
Whereas IL-6 and TNF-α transcription was increased
with TLR4 and TLR7 activation in caspase-8–deficient
BMDMs, these BMDMs produced higher levels of IL-6
and TNF-α in response to TLR4, TLR7, and TLR9
ligation compared with control BMDMs (Fig. 5a and
Additional file 1: Figure S7c). Transcription of IL-6 was
reduced with Nec-1 in response to TLR4, TLR7, and
TLR9 ligation and with RIPK3 deletion in response to
TLR4 activation (Fig. 5a). In addition, RIPK1 blockade
reduced transcription of TNF-α in caspase-8–deficient
BMDMs following stimulation with TLR4 and TLR7
(Additional file 1: Figure S7c). Similarly to transcription,
blockade of RIPK1 reduced production of TNF-α by
CreLysMCasp8fl/fl BMDMs in response to TLR4, TLR7,
and TLR9 activation. However, suppression of RIPK1 af-
fected only IL-6 following TLR7 and TLR9 activation. In
contrast, deletion of RIPK3 reduced TNF-α production
by CreLysMCasp8fl/fl BMDMs in response to TLR7 and
TLR9 activation and IL-6 in response to TLR7 activation
(Fig. 5a and Additional file 1: Figure S7C). Elevated tran-
scription and hypersecretion of IL-1β without the require-
ment for ATP was observed with TLR4, TLR7, and TLR9
ligation in CreLysMCasp8fl/fl BMDMs and was also blocked
by the addition of Nec-1 or by RIPK3 deletion (Additional
file 1: Figure S7D). Further, IL-1β was secreted at increased
levels, and abrogated by Nec-1, in CreLysMCasp8fl/fl BMDMs
compared with control BMDMs following stimulation with
TLR4, TLR7, and TLR9 and addition of ATP (Additional
file 1: Figure S7E).
The environmental milieu has been shown to influence
macrophages to assume alternate phenotypes. We exam-
ined whether caspase-8 was involved in the polarization
of BMDMs to classically activated M1 macrophages that
are proinflammatory or to alternatively activated M2
macrophages that are necessary for repair. Polarization
of BMDMs was analyzed via gene expression using a
custom QuantiGene 2.0 panel [20] (see Additional file 1:
Table S1) following stimulation with IFN-γ/LPS (M1-
skewing media) and IL-4 (M2-skewing media). Among
the 52 genes included in the panel, those genes that were
differentially expressed between populations of BMDMs
according to selected criteria (differentially expressed in
at least one two-group comparison with Bonferroni-
corrected p value <0.05) can be found in Additional file
2. Further, heat maps were generated to visualize differ-
ential gene expression between unstimulated control
and caspase-8–deficient BMDMs (Additional file 1:
Figure S8A), CreLysMCasp8fl/fl BMDMs with and without
Nec-1 (Additional file 1: Figure S8B), M1-polarized
control and CreLysMCasp8fl/fl BMDMs (Additional file 1:
Figure S8C), unstimulated CreLysMCasp8fl/fl and M1-
polarized CreLysMCasp8fl/fl BMDMs (Additional file 1:
Figure S8D), M1-polarized CreLysMCasp8fl/fl with and
without Nec-1 (Additional file 1: Figure S8E), M2-polarized
control and CreLysMCasp8fl/fl BMDMs (Additional file 1:
Figure S8F), unstimulated CreLysMCasp8fl/fl and M2-
polarized CreLysMCasp8fl/fl BMDMs (Additional file 1:
Figure S8G), and M2-polarized CreLysMCasp8fl/fl with and
without Nec-1 (Additional file 1: Figure S8H). PCA re-
vealed that unstimulated caspase-8–deficient BMDMs
cluster separately from control BMDMs, whereas BMDMs
(See figure on previous page.)
Fig. 3 Caspase-8 deficiency alters the macrophage TLR response in vivo but does not affect cell survival. a Splenocytes from 6–8-month-old (aged)
female Casp8fl/fl (control) and CreLysMCasp8fl/fl mice (n≥ 7) were analyzed by flow cytometry. Shown are representative fluorescence-activated cell
sorting (FACS) plots of splenic CD11b+F4/80+Ly6Chigh and CD11b+F4/80+Ly6Clow populations displaying relative levels of TLR expression. b and
c Representative FACS plots and quantitative graphs of results representing the fold change in CD86 expression over PBS injection alone. b 3-month-
old control and CreLysMCasp8fl/fl mice (n = 4) that received LPS or CpG injection (200 μg/mouse) were evaluated 4 h later for splenic CD11b+F4/80+
Ly6Chigh cell expression of CD86. c Serum levels of cytokines and chemokines from TLR agonist–injected mice. d and e 3-week-old control and
CreLysMCasp8fl/fl mice (n = 4) treated with oral antibiotics (ampicillin, vancomycin, neomycin sulfate, metronidazole) for 8 weeks were evaluated for
d spleen weight and e cervical lymph node weight. f–l Mice reconstituted with equal portions of B6.CD45.1 (wild-type [WT]) and either control or
CreLysMCasp8fl/fl FACS-sorted LSK populations (n = 5) were maintained on low-dose oral antibiotics. f Representation of chimera generation. Chimeric
mice were evaluated 8 months posttransfer for g splenomegaly, h lymphadenopathy, i proteinuria, j serum cytokine and chemokine levels, k myeloid
cell subset numbers, and l distribution of WT (45.1)-derived and control or CreLysMCasp8fl/fl (45.2)-derived myeloid populations. Data are represented as
mean ± SD and were compared by Mann–Whitney U test: *p< 0.05; **p< 0.005; ***p< 0.0005. TLR Toll-like receptor, Casp8 caspase-8, LPS lipopolysaccharide,
PBS phosphate-buffered saline, IL interleukin, Gro-α growth-regulated oncogene-α, IFN interferon, Ig immunoglobulin, KC keratinocyte chemoattractant,
TNF tumor necrosis factor, sRANKL soluble receptor activator of nuclear factor κB ligand, LN lymph node, WT wild type, MCP monocyte chemoattractant
protein, LSK lineage-negative, Sca-1+, c-kit+
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incubated with the inhibitor of caspase-8 enzymatic activ-
ity, Z-IETD-FMK, cluster more closely with control
BMDMs (Fig. 5b). Further, Casp8fl/fl, Casp8fl/fl + Z-IETD-
FMK, and CreLysMCasp8fl/fl BMDMs behaved similarly
in response to M2-skewing media (Fig. 5b). However,
CreLysMCasp8fl/fl BMDMs clustered independently from
both Casp8fl/fl and Casp8fl/fl + Z-IETD-FMK BMDMs in
response to M1-skewing media (Fig. 5b). In all instances,
the addition of Nec-1 restored caspase-8–deficient BMDM
populations to those of control BMDMs (Fig. 5c). These
data suggest not only that caspase-8 is involved in the sup-
pression of macrophage responses to TLR activation in an
RIPK1- and RIPK3-dependent manner, but also that
caspase-8 controls macrophage polarization in response to
M1-skewing media in an RIPK1-dependent fashion.
Discussion
Our data suggest that caspase-8 controls the response of
macrophages to TLR activation and M1-skewing media by
dampening RIPK activity. CreLysMCasp8fl/fl mice develop a
mild systemic inflammatory disease characterized by
splenomegaly, lymphadenopathy, immune complex de-
position in the kidney, proteinuria, and elevated amounts
of serum cytokines and antibodies. The observed spleno-
megaly is not attributable to increased numbers of spleno-
cytes, indicating that the spleen may be enlarged for other
reasons, such as increased red blood cell numbers or ele-
vated collagen deposition. Although we observed in-
creased Ly6Chigh and Ly6Clow CD11b+F4/80+ splenic
populations, analysis of mixed bone marrow chimeric
mice reveals that these caspase-8–deficient populations
are not preferentially expanded, indicating that perhaps
disease progression, rather than lack of caspase-8, in-
creases these populations, potentially through increased
migration, decreased egress, and/or enhanced prolifera-
tion of progenitor populations. Further, the systemic in-
flammatory phenotypes in CreLysMCasp8fl/fl mice may
arise independently of the role of caspase-8 in survival, as
mixed bone marrow chimeric mice are reconstituted with
equal proportions of normal and caspase-8–deficient
splenic populations. Moreover, deletion of RIPK3 is suffi-
cient to prevent inflammation in CreLysMCasp8fl/fl mice
and restore the CD11b+F4/80+ splenic populations to
those of control mice. The increased CD11b+F4/80+
splenic populations indicate that the absence of caspase-8
does not lead to rampant necroptosis due to RIPK3 action,
as is the case with T-cell caspase-8 deficiency [21]. Further,
if insufficient apoptosis due to the lack of caspase-8 was
the cause of increased CD11b+F4/80+ splenic populations,
deletion of RIPK3 would exacerbate rather than correct
this phenotype, as necroptosis would also be prevented.
Rather, these data suggest that caspase-8 functions to sup-
press RIPK activity in myeloid populations independent of
their roles in cell death.
Upon TLR stimulation, caspase-8–deficient BMDMs
produce elevated proinflammatory cytokines, in part due
to rampant RIPK1 and RIPK3 activity, as the addition of
Nec-1 or RIPK3 deletion blocks production. Further, com-
pared with controls, CreLysMCasp8fl/fl mice show an expan-
sion of costimulatory CD86 expression on Ly6ChighCD11b+
F4/80+ splenocytes upon injection with TLR4 and TLR9
agonists. These results are similar to those observed in
CreCD11cCasp8fl/fl mice, in that caspase-8–deficient
BMDCs also produce elevated levels of proinflammatory
cytokines and respond to in vivo TLR7 activation by hy-
peractivation of splenic CD11c+CD8− DCs compared with
controls [10]. However, caspase-8 function diverges in
myeloid cells and DCs upon elimination of the gut micro-
flora. The gut microflora are a means to maintain homeo-
stasis in the gut, but these microbes have also been
suggested to be a reservoir of endogenous TLR ligands
[19]. When the immune system is compromised, as with
the case of caspase-8 deletion, the response to these mi-
crobial pathogen-associated molecular patterns (PAMPs)
may go awry. Whereas treatment with oral antibiotics is
ineffective at reducing the systemic inflammation in
(See figure on previous page.)
Fig. 4 RIPK3 deletion prevents inflammation in CreLysMCasp8fl/fl mice. 2–3-month-old (young) and 6–8-month-old (aged) female Casp8fl/fl (control),
CreLysMCasp8fl/fl, and RIPK3−/−CreLysMCasp8fl/fl mice (n≥ 4) were evaluated for systemic autoimmune disease phenotypes, and splenocytes from aged
mice were analyzed by flow cytometry. a Spleen weights of young and aged mice. b Total numbers of live splenocytes from aged mice. c Cervical
lymph node weights of young and aged mice. d Formalin-fixed kidney sections (5 μm) from aged mice stained with periodic acid–Schiff (PAS).
e Kidney scores of aged mice. f Proteinuria of aged mice assessed using Uristix reagent strips. Serum from aged mice was evaluated for levels of
g ssDNA-, dsDNA-, histone-, and chromatin-reactive IgG antibodies and h cytokines and chemokines. i Number of CD11b+F4/80−Ly6G+ neutrophils,
Ly6Chigh and Ly6Clow CD11b+F4/80+ cells and CD11b−F4/80+ red pulp macrophages. j Number of CD11c+CD8− and CD11c+CD8− conventional DCs and
CD11cintermediatePDCA-1+B220+ plasmacytoid DCs. k Total B-cell (CD11c−B220+) numbers. l B-cell subsets: follicular (FO; CD19+CD21/35+CD23+), marginal
zone (MZ; CD19+CD21/35+CD23low), transitional 1 (T1; B220+AA4.1+CD23−), transitional 2 (T2; B220+AA4.1+CD23+), plasmablasts (PB; CD19+B220lowCD138
+CD21/35−CD23−), and plasma cells (PC; CD19+B220+CD138+CD21/35−CD23−). m Total CD4+ and CD8+ T-cell numbers. Naïve (CD44−CD62L+), central
memory (CD44+CD62L+), and activated (CD44+CD62L−) n CD4+ and o CD8+ T-cell numbers. p CD4−CD8−CD3+B220+ double-negative T-cell numbers.
q CD4+CD25+Foxp3+ regulatory T-cell numbers. a–h represent analyses that included data from control and CreLysMCasp8fl/fl mice shown in Figs. 1b–d,
f–h, and j. Data are represented as mean ± SD and were compared by Mann–Whitney U test: *p< 0.05; **p< 0.005; ***p< 0.0005. Casp8 caspase-8, LPS
lipopolysaccharide, IL interleukin, Gro-α growth-regulated oncogene-α, IFN interferon, Ig immunoglobulin, KC keratinocyte chemoattractant, TNF tumor
necrosis factor, MCP monocyte chemoattractant protein, LN, lymph node, OD optical density, RIPK receptor-interacting serine/threonine protein kinase,
PDCA-1 plasmacytoid dendritic cell antigen 1, sRANKL soluble receptor activator of nuclear factor κB ligand
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CreCD11cCasp8fl/fl mice [10], this same treatment prevents
splenomegaly and lymphadenopathy in CreLysMCasp8fl/fl
mice. These results suggest that caspase-8 signals via
mechanisms in myeloid cells different from those in DCs
and that caspase-8 in myeloid populations potentially con-
trols the response to endogenous gut microflora. Further,
the impact of oral antibiotic treatment mimics the effect
of RIPK3 deletion in CreLysMCasp8fl/fl mice, indicating a
potential involvement of RIPK3 in the maintenance of tol-
erance to gut microflora. An alternate explanation could
be that necroptotic macrophages in the gut release
damage-associated molecular patterns (DAMPs) capable
of activating other cells previously “primed” by gut micro-
flora [22]. Removal of the gut microflora would prevent
this priming, thus inhibiting activation of the immune sys-
tem by DAMPs released by necroptotic macrophages and
systemic inflammation.
Conditional deletion has revealed roles for caspase-8 in a
number of cell death–independent activities. TLR4, TLR7,
and TLR9 activation induces hyperproduction of proin-
flammatory cytokines in caspase-8–deficient BMDMs.
Similar to caspase-8–deficient DCs [10], blocking RIPK1
kinase activity dampens the TLR-induced secretion of
proinflammatory cytokines in caspase-8–deficient macro-
phages. TLR engagement can induce RIPK signaling inde-
pendent of DR activation, thereby leading to formation of
a ripoptosome, a complex containing proteins that partici-
pate in necroptosis, including RIPK1, caspase-8, and cFLIP
[8, 23]. Recent evidence suggests that ripoptosome activity
and RIPK3 signaling in BMDMs can induce production of
proinflammatory cytokine IL-1β in a caspase-8–dependent
manner [6] independent of cell death. Both caspase-
8–deficient BMDCs [10] and BMDMs secrete elevated IL-
1β in response to TLR activation with the addition of
ATP. Nec-1 decreases this IL-1β secretion in both control
and casapse-8–deficient BMDCs [10] and BMDMs, albeit
to a lesser extent, indicating that RIPK1 is potentially in-
volved in IL-1β release independent of caspase-8. In
addition, we and others have shown that caspase-8–defi-
cient BMDCs activated by LPS secrete IL-1β without the
requirement for secondary ATP stimulation [5, 10]. Fur-
ther, we previously reported that this secretion of IL-1β by
BMDCs also occurs via TLR7 and TLR9 activation [10].
Similar to our previous findings with BMDCs, we show
that caspase-8–deficient BMDMs secrete IL-1β without
the requirement for secondary ATP stimulation in re-
sponse to TLR4, TLR7, and TLR9 activation and that this
secretion is abrogated by the addition of Nec-1 and dele-
tion of RIPK3. Thus, our data implicate caspase-8 in the
suppression of the macrophage TLR response in a manner
that may require the components of the ripoptosome.
SLE is a severe multisystem autoimmune disease charac-
terized by an immune response mounted against nuclear
self-antigens that results in multiple tissue and/or organ
damage. Loss of Fas in myeloid cells [9] or loss of caspase-8
in DCs [10] results in a SLE-like disease. Although
CreLysMCasp8fl/fl mice present with hallmarks of SLE-like
disease, these phenotypes are markedly less robust than
those observed in CreLysMFasfl/fl or CreCD11cCasp8fl/fl mice.
Similar to CreLysMCasp8fl/fl mice, CreLysMFADDfl/fl mice
develop a mild systemic inflammation that is reversed
by RIPK3 deletion [24]. These results indicate that Fas,
FADD, and caspase-8 play a cell-type–specific role in sup-
pressing autoimmune phenotypes. Although CreLysMFasfl/fl,
CreLysMFADDfl/fl and CreLysMCasp8fl/fl myeloid populations
are numerically dysregulated, their activation status is not
altered. In contrast, CreCD11cCasp8fl/fl DC populations dis-
play an elevated expression of costimulatory molecules.
Further, the splenomegaly observed in CreLysMCasp8fl/fl
does not result in increased lymphocyte populations,
which is different from the situation in CreLysMFasfl/fl
and CreLysMFADDfl/fl mice [9, 24]. However, both caspase-
8– and Fas-deficient macrophages are unable to directly
induce T-cell proliferation in mixed leukocyte reactions.
Thus, these data suggest that, in myeloid cell–specific
caspase-8– or Fas-deficient mice, the effect on lympho-
cytes is indirect and may be mediated by cytokines or by a
macrophage-specific paracrine effect on nonlymphocytic
cells such as DCs.
Investigators in previous studies have examined the ef-
fect of myeloid cell–specific caspase-8 deletion [5, 14].
In contrast to the data presented here, there was a fail-
ure to produce M-CSF-stimulated BMDMs from mye-
loid cell–specific caspase-8–deficient bone marrow.
Additionally, there was no in vivo dysregulation of
macrophage populations. These previous findings con-
flict with the present studies in that CreLysMCasp8fl/fl
mice present increased numbers of both Ly6Chigh and
(See figure on previous page.)
Fig. 5 Caspase-8 deficiency in macrophages alters the response to Toll-like receptor activation and macrophage polarization in vitro. a Casp8fl/fl
(control), CreLysMCasp8fl/fl, RIPK3−/−, and RIPK3−/−CreLysMCasp8fl/fl BMDMs were stimulated with LPS (10 ng/ml), imiquimod (5 μg/ml), and CpG
(5 μg/ml) with or without Nec-1 (30 μM) for 3, 6, and 12 h and evaluated for transcript and supernatant levels of IL-6. Data are represented as
mean ± SD of biological triplicates, and experiments were repeated twice. b and c Control, control + Z-IETD-FMK (20 μM), and CreLysMCasp8fl/fl
BMDMs were cultured with M1-polarizing conditions (primed overnight with IFN-γ 100 ng/ml and stimulated for 3 h with LPS 10 ng/ml) and
M2-polarizing conditions (stimulated for 24 h with IL-4 40 ng/ml) with or without Nec-1. Principal component analysis of gene expression was
performed in BMDMs under (b) M1- and M2-polarizing conditions and (c) M1- and M2-polarizing conditions + Nec-1. Data are represented as
biological triplicates. FMK fluoromethylketone, IFN interferon, IL interleukin, LPS lipopolysaccharide, Nec-1 necrostatin-1, PCA principal component
analysis, Z-IETD Z-Ile-Glu-(O-ME)-Thr-Asp-(O-Me)
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Ly6Clow splenic CD11b+F4/80+ cells. Further, previous
studies did not show caspase-8 deletion in peritoneal
neutrophils, which is in contrast to the complete dele-
tion of caspase-8 in CreLysMCasp8fl/fl splenic neutrophils.
The conflicting results observed between the CreLysM-
Casp8fl/fl mice and previously published strains presum-
ably stem from differences in the generation of in vitro
bone marrow–derived populations and the cell-specific
caspase-8 deletion constructs. In the present study,
BMDMs were generated with M-CSF, whereas researchers
in previous studies relied on the use of L929 media, which
can contain unpredictable levels of M-CSF as well as other
unknown components. Additionally, in the present study,
both alleles of caspase-8 are floxed, whereas previous stud-
ies floxed only one allele of caspase-8 and the other was
deleted [14]. Because caspase-8 has been shown to be ne-
cessary for early myeloid progenitor formation [25, 26], de-
letion of caspase-8 in mice that have only one allele of
caspase-8 may increase selective pressure on these cells.
Thus, in this scenario, the cells that have complete deletion
will die before becoming monocytes or macrophages,
whereas others that fail to delete caspase-8 live and are not
selected. However, in mice with two alleles of floxed
caspase-8, progenitor deletion of caspase-8 may not be
complete but caspase-8 is fully deleted as cells mature
(Additional file 1: Figure S1), thereby allowing for cell sur-
vival throughout the differentiation process.
Conclusions
In CreLysMCasp8fl/fl mice, activation of TLRs, potentially via
PAMPs derived from gut microflora, may lead to increased
RIPK1 and RIPK3 activity, induction of costimulatory
molecules, and increased production of proinflammatory
cytokines, ultimately culminating in a mild systemic inflam-
matory disease. Our data suggest that, under steady-state
conditions, following TLR activation of myeloid cells by the
gut microflora, caspase-8 associates with RIPK1 and RIPK3
and limits their downstream signaling, thereby preventing
the continued activation of these cells to keep systemic
inflammation in check. These data provide a macrophage-
specific link between caspase-8 and the heightened TLR re-
sponses to endogenous ligands leading to inflammation
and show, for the first time to our knowledge, that caspase-
8 controls the macrophage response to TLR activation and
polarization.
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